Stevo Julius 1929-2025

prof. Sverre Erik Kjeldsen

Medical inertia: definition and current landscape in Europe

Monika Hollander

Medication adherence in hypertension: a Polish example

prof. dr hab. n. med. Aleksander Prejbisz

Emotional aspects

prof. Alexandre Persu

Training and medical education and adherence

dr n. med. Anna Szyndler

To listen to and understand the patient

dr n. med. Piotr Wierzbiński

Transformative treatment paradigm shift for the adaptive adherence measures and patient-focused recovery

dr hab. n. med. Wiesław Jerzy Cubała, prof. nadzw.

Socioeconomic environment and adherence

Marie Ekenberg

Does renal denervation improve medication adherence?

prof. Michel Azizi

Very long-acting drugs and long-term persistence to medications

prof. A.H. Jan Danser

Adherence in patients with a high pill burden: the example of nephrology

prof. dr hab. n. med. Marcin Adamczak

How to detect poor adherence in clinical practice

prof. Jan Vaclavik

Measuring drug levels in blood or urine: advantages and limits

dr Pankaj Gupta

Can deprescription improve adherence?

prof. Michel Burnier

Digital health and wearable technologies

prof. Grégoire Würzner

Physician adherence to the study protocol in hypertension outcome trials ("investigator inertia")

prof. Sverre Erik Kjeldsen

Managing uncertainty in drug exposure to minimize the risk of trial failure

dr Bernard Vrijens

EMERGE: Recommendations for adherence monitoring in trials

Lina Eliasson

Can pharmacist collaboration be helpful to support adherence?

prof. Marie Schneider

The role of nurses in the management of adherence

Sara Soldan

Can assessment of vascular age improve adherence and medical inertia in hypertension?

dr Thomas Weber

Real world studies based on country-wide registry

prof. Björn Wettermark

Is it possible to perform a RCT on drug adherence?

prof. Reinhold Kreutz

Could “omics” contribute to improve adherence?

prof. Christian Delles